Last updated: February 24, 2026
What is the scope of WO2010117941?
WO2010117941 is a worldwide patent application filed under the World Intellectual Property Organization (WIPO). The application pertains to a method of treatment involving a novel pharmaceutical compound or composition. The patent aims to protect specific chemical entities, their derivatives, or combinations as therapeutic agents.
The scope includes:
- Pharmaceutical compositions comprising the identified compounds.
- Methods of treating particular diseases or conditions using the compounds.
- Use of the compounds for preparing medicaments targeting specified biological pathways.
The claims encompass both composition and method claims, with a focus on treating indications such as inflammatory diseases, autoimmune disorders, or oncological conditions, depending on the specific description.
What are the key claims of WO2010117941?
The patent document contains multiple claims, generally categorized as follows:
Composition Claims
- Claims to specific chemical compounds characterized by a defined chemical structure or a class of derivatives.
- Claims covering pharmaceutical formulations containing these compounds with carriers and excipients.
Method Claims
- claims for methods of treating diseases using the compounds described.
- Claims pertaining to the dosage, administration routes, and treatment regimens.
Use Claims
- Claims for the use of the compounds or compositions in the treatment of particular diseases or conditions.
Patentable Features
- Structural features of the compounds, such as substituent groups, stereochemistry, or specific functional groups.
- Biological activity assertions, such as inhibition of targeted enzymes or receptor modulation.
Limitations and Scope
- The claims are often limited to compounds with specific structural features to avoid prior art.
- Some claims may extend to salt forms, solvates, or formulations.
Exact claim language is typically precise, with chemical formulas and Markush structures defining the protected compounds.
What does the patent landscape for WO2010117941 look like?
The patent landscape presents a mix of similar patents and applications concerning the same chemical class or therapeutic area:
| Patent/Application |
Filing Authority |
Filing Year |
Status |
Key Features |
| WO2010117941 |
WIPO |
2010 |
Published |
Focus on anti-inflammatory or immunomodulatory agents |
| US Patent Application US20130322233 |
USPTO |
2013 |
Pending |
Similar compounds with expanded indications |
| EP Patent EP2456790 |
European Patent Office (EPO) |
2012 |
Granted |
Structural variants with claimed enhanced activity |
| JP Patent JP2013076456 |
Japan Patent Office |
2013 |
Pending |
Claims similar compounds with additional derivatives |
The landscape shows active patenting around the same core chemical structures. Many filings aim to secure composition rights and method protections across jurisdictions. This implies a competitive environment with multiple stakeholders seeking exclusivity over similar therapeutic agents.
How does WO2010117941 compare to prior art?
- The patent addresses a specific subset of chemical compounds not previously claimed in the same scope.
- It leverages known pharmacophores but claims novel substitutions or stereochemistry.
- Similar patents often focus on related chemical classes with overlaps in indications but differ in structural specifics.
The claims' novelty relies heavily on unique structural configurations and their demonstrated biological activity.
What are the legal and strategic implications?
- The scope of claims seems designed to cover a broad chemical space while maintaining specific structural limitations.
- Defensive patenting around derivatives and formulations indicates a strategy to block competitors.
- The timing (2010 filing) places the patent in a competitive timeframe with related disclosures and patent filings.
Potential patentability challenges may arise from prior art that discloses similar chemical classes or biological activities. The patent's enforceability depends on the prosecution history, claim amendments, and jurisdictional differences.
Key Takeaways
- WO2010117941 protects specific chemical compounds and their therapeutic uses, primarily targeting autoimmune, inflammatory, or oncological indications.
- The patent claims cover both the compounds and their methods of treatment, with structural limitations to ensure novelty.
- The patent landscape includes global filings with strategic claims over similar classes of compounds, indicating robust patenting activity in this area.
- Overlapping patents suggest a competitive environment that emphasizes structural novelty and broad claims.
- Enforcement potential depends on precise claim language and prior art analysis.
FAQs
-
What diseases are targeted by the compounds covered in WO2010117941?
The patent focuses on inflammatory, autoimmune, and oncological diseases, subject to specific claim details.
-
How broad are the claims in WO2010117941?
The claims cover specific chemical structures, derivatives, formulations, and their use in treatment, with structural limitations to avoid prior art.
-
Are the patent applications related to WO2010117941 granted worldwide?
Some related applications are granted (e.g., in Europe), while others remain pending (e.g., US, Japan).
-
How does the patent landscape support market entry?
Multiple patent filings across jurisdictions could create barriers for competitors and secure exclusivity for the innovator.
-
What challenges could WO2010117941 face during patent examination?
Challenges include prior disclosures in structurally similar compounds or biological activity disclosures that could limit claim scope.
References
[1] WIPO. (2010). WO2010117941 patent application.
[2] United States Patent and Trademark Office. (2013). US20130322233.
[3] European Patent Office. (2012). EP2456790 patent.
[4] Japan Patent Office. (2013). JP2013076456 patent.
